Better Late than Early: FDG-PET Imaging in Metastatic Renal Cell Carcinoma

被引：8
作者：
Harrison, Michael R. [1 ,3 ]
George, Daniel J. [1 ,2 ,3 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA
[3] Duke Canc Inst, Durham, NC USA
来源：
CLINICAL CANCER RESEARCH | 2011年 / 17卷 / 18期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; SUNITINIB;
D O I：
10.1158/1078-0432.CCR-11-1768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sunitinib treatment benefits patients with metastatic renal cell carcinoma (mRCC), but response duration can vary widely and resistance is not predicted by standard measures. [F-18]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET) uptake is variable in mRCC, but changes in FDG-PET uptake may be useful in monitoring disease progression. Further work is needed to personalize treatment for patients with mRCC. Clin Cancer Res; 17(18); 5841-3. (C) 2011 AACR.
引用
收藏
页码：5841 / 5843
页数：3
相关论文
共 12 条
[1]  
Bjarnason GA, 2011, J CLIN ONCOL, V29, P4627
[2]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[3]   Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study [J].
Heng, Daniel Y. C. ;
Xie, Wanling ;
Regan, Meredith M. ;
Warren, Mark A. ;
Golshayan, Ali Reza ;
Sahi, Chakshu ;
Eigl, Bernhard J. ;
Ruether, J. Dean ;
Cheng, Tina ;
North, Scott ;
Venner, Peter ;
Knox, Jennifer J. ;
Chi, Kim N. ;
Kollmannsberger, Christian ;
McDermott, David F. ;
Oh, William K. ;
Atkins, Michael B. ;
Bukowski, Ronald M. ;
Rini, Brian I. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) :5794-5799
[4]   Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer [J].
Kayani, Irfan ;
Avril, Norbert ;
Bomanji, Jamshed ;
Chowdhury, Simon ;
Rockall, Andrea ;
Sahdev, Anju ;
Nathan, Paul ;
Wilson, Peter ;
Shamash, Jonathan ;
Sharpe, Kevin ;
Lim, Louise ;
Dickson, John ;
Ell, Peter ;
Reynolds, Andrew ;
Powles, Thomas .
CLINICAL CANCER RESEARCH, 2011, 17 (18) :6021-6028
[5]   Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers [J].
Kontovinis, Loukas F. ;
Papazisis, Konstantinos T. ;
Touplikioti, Panagiota ;
Andreadis, Charalambos ;
Mouratidou, Despoina ;
Kortsaris, Alexandros H. .
BMC CANCER, 2009, 9
[6]   Pharmacodynamic study of FLT-PET imaging in patients treated with sunitinib [J].
Liu, G. ;
Jeraj, R. ;
Perlman, S. ;
Vanderhoek, M. ;
Kolesar, J. ;
Eickhoff, J. ;
Alberti, D. ;
Wilding, G. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[7]   Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer [J].
Miyakita, H ;
Tokunaga, M ;
Onda, H ;
Usui, Y ;
Kinoshita, H ;
Kawamura, N ;
Yasuda, S .
INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (01) :15-18
[8]   Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Pili, Roberto ;
Bjarnason, Georg A. ;
Garcia-del-Muro, Xavier ;
Sosman, Jeffrey A. ;
Solska, Ewa ;
Wilding, George ;
Thompson, John A. ;
Kim, Sindy T. ;
Chen, Isan ;
Huang, Xin ;
Figlin, Robert A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) :3584-3590
[9]   Early Prediction of Response to Sunitinib After Imatinib Failure by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Gastrointestinal Stromal Tumor [J].
Prior, John O. ;
Montemurro, Michael ;
Orcurto, Maria-Victoria ;
Michielin, Olivier ;
Luthi, Francois ;
Benhattar, Jean ;
Guillou, Louis ;
Elsig, Valerie ;
Stupp, Roger ;
Delaloye, Angelika Bischof ;
Leyvraz, Serge .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) :439-445
[10]   Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma [J].
Revheim, M. E. ;
Winge-Main, A. K. ;
Hagen, G. ;
Fjeld, J. G. ;
Fossa, S. D. ;
Lilleby, W. .
CLINICAL ONCOLOGY, 2011, 23 (05) :339-343
12